Hi Denial, why don’t you do some serious research then and make a meaningful contribution to the discussion.
I do feel you are much more interested in PAR’s “near term future success” than our enduring long term success.
You obviously have concerns and doubts about PAR and that is fine. This is a pre revenue, Pre approved high risk biotech with a large MC after all.
So why not start a new thread with your concerns and explain in detail your points if you want to encourage serious discourse. We can’t expect everyone else to always do the work.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)